#367 - Tylenol, pregnancy, and autism: What recent studies show and how to interpret the data

#367 - Tylenol, pregnancy, and autism: What recent studies show and how to interpret the data

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter's Weekly Newsletter

In this special episode of The Drive, Peter addresses the recent headlines linking acetaminophen (Tylenol) use during pregnancy to autism in exposed children. Recognizing the confusion these claims have sparked among patients, listeners, and the broader public, Peter uses this episode to provide a framework for thinking critically about complex conditions and the research related to them. He highlights the dramatic rise in autism diagnoses over recent decades, noting that multifactorial conditions rarely have a single cause, and emphasizes the importance of resisting oversimplified explanations. Peter also stresses that humans are not naturally wired for scientific thinking, making disciplined frameworks like the Bradford Hill criteria essential for evaluating causality in epidemiology. Ultimately, he uses this framework to explore the evidence surrounding acetaminophen use during pregnancy and its potential link to autism.

We discuss:

  • Laying the groundwork for this discussion, the rise in autism rates, and the value in using frameworks [1:00];
  • The FDA pregnancy drug categories, where Tylenol falls within that framework, and a structured method for evaluating scientific evidence and causality [6:00];
  • What exactly are the claims being made about acetaminophen and autism? [13:45];
  • The increase in autism rates and why so many things are being linked to autism: the multiple comparisons problem [15:00];
  • Evaluating the review paper that triggered the recent concern over acetaminophen and autism [21:45];
  • Breaking down the largest studies on prenatal Tylenol exposure and autism: is there a causal link? [35:00];
  • Why observational studies can't prove causality, the role of confounding variables, and the importance of frameworks like the Bradford Hill criteria [43:30];
  • Applying the Bradford Hill criteria: testing the case for Tylenol and autism [45:45];
  • Putting it all together to answer the question: Does acetaminophen use during pregnancy increase the risk of autism? [56:15];
  • If autism risk is overwhelmingly genetic, what explains the dramatic rise in autism diagnoses? [59:15];
  • Other risk factors for autism: parental age, maternal health, environment, and where Tylenol fits in [1:09:15];
  • Medication use during pregnancy: balancing risks, benefits, and FDA categories [1:15:15];
  • Considerations for taking Tylenol during pregnancy [1:19:30];
  • Final thoughts: critical thinking, balanced risk assessment, and the importance of context when evaluating medications like Tylenol during pregnancy [1:22:30]; and
  • More.

Connect With Peter on Twitter, Instagram, Facebook and YouTube

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(453)

#405 ‒ AMA #88: Metabolic liver health: how to assess risk, catch dysfunction early, and prevent or reverse liver disease

#405 ‒ AMA #88: Metabolic liver health: how to assess risk, catch dysfunction early, and prevent or reverse liver disease

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this "Ask Me Anything" (AMA) episode, Peter takes a deep dive i...

24 Elo 39min

#404 ‒ Mental health beyond neurotransmitters: the role of hormones in psychiatry, why symptom reduction isn't enough, and the future of psychedelic therapies | Linus Abrams, M.D.

#404 ‒ Mental health beyond neurotransmitters: the role of hormones in psychiatry, why symptom reduction isn't enough, and the future of psychedelic therapies | Linus Abrams, M.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter sits down with Dr. Linus Abrams, a psychiat...

17 Elo 2h 17min

#403 ‒ Peptides: separating scientific promise from marketing hype

#403 ‒ Peptides: separating scientific promise from marketing hype

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter returns to the topic of peptides, offering ...

10 Elo 53min

#402 ‒ NMR blood analysis: how heart disease risk, insulin resistance, inflammation, and mortality risk can be assessed from a single blood sample | Jim Otvos, Ph.D.

#402 ‒ NMR blood analysis: how heart disease risk, insulin resistance, inflammation, and mortality risk can be assessed from a single blood sample | Jim Otvos, Ph.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Jim Otvos is a biophysical chemist who pioneered the use of nuclea...

3 Elo 2h 25min

#401 ‒ How curiosity transforms medicine: extraordinary discoveries that changed modern healthcare

#401 ‒ How curiosity transforms medicine: extraordinary discoveries that changed modern healthcare

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode of The Drive, Peter explores how seemingly obscure...

27 Heinä 1h 4min

#400 ‒ AMA #87: Environmental pollution and longevity: air pollution, noise, light, EMFs, and practical strategies to mitigate health risks

#400 ‒ AMA #87: Environmental pollution and longevity: air pollution, noise, light, EMFs, and practical strategies to mitigate health risks

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this "Ask Me Anything" (AMA) episode, Peter explores the eviden...

20 Heinä 19min

#399 ‒ The evolution of Alzheimer's disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.

#399 ‒ The evolution of Alzheimer's disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Gayatri Devi is a nationally recognized neurologist specializing i...

13 Heinä 1h 56min

Building strength and muscle mass: how to optimize training, nutrition, and more for longevity (AMA #71 rebroadcast)

Building strength and muscle mass: how to optimize training, nutrition, and more for longevity (AMA #71 rebroadcast)

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this "Ask Me Anything" (AMA) episode, Peter dives deep into the...

6 Heinä 1h 44min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
tiedenaiset-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
rss-pitaisko-erota
psykopodiaa-podcast
meditaatiot-suomeksi
voi-hyvin-meditaatiot-2
terapiassa
katilon-kahvitunti
rss-kuumilla-aalloilla
rss-pt-paahtio
paritellen
selviytyjat-tarinoita-elamasta
kehorauhaa
rss-vapaudu-voimaasi
rss-seksicast
docemilia
fitnessvastaanotto
junnut-pelissa
rss-uplevel-by-sonja-hannus